Sichuan Kelun-Biotech Turns to Profit in H1 as Revenue Jumps 32%

MT Newswires Live08-20

Sichuan Kelun-Biotech Biopharmaceutical (HKG:6990) swung to an attributable profit of 310.2 million yuan in the first half from a loss of 31.1 million yuan in the year-ago period, according to a Monday filing with the Hong Kong stock exchange.

The biopharmaceutical company turned to EPS of 1.41 yuan from a loss per share of 0.17. Analysts at Visible Alpha estimated a loss per share of 1.17 yuan.

Revenue grew 32% to 1.38 billion yuan from 1.05 billion yuan a year earlier. Visible Alpha analysts forecast revenue at 7.11 billion yuan.

Shares slid 2% during Tuesday's afternoon trading.

Price (HKD): $166.80, Change: $-2.6, Percent Change: -1.53%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2460046956?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-20 13:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2460046956","market":"sg","top_or_hot":-1,"title":"Sichuan Kelun-Biotech Turns to Profit in H1 as Revenue Jumps 32%","media":"MT Newswires Live","content":"<html><body><p> Sichuan Kelun-Biotech Biopharmaceutical (HKG:6990) swung to an attributable profit of 310.2 million yuan in the first half from a loss of 31.1 million yuan in the year-ago period, according to a Monday filing with the Hong Kong stock exchange.</p><p>The biopharmaceutical company turned to EPS of 1.41 yuan from a loss per share of 0.17. Analysts at Visible Alpha estimated a loss per share of 1.17 yuan.</p><p>Revenue grew 32% to 1.38 billion yuan from 1.05 billion yuan a year earlier. Visible Alpha analysts forecast revenue at 7.11 billion yuan.</p><p>Shares slid 2% during Tuesday's afternoon trading.</p><p>Price (HKD): $166.80, Change: $-2.6, Percent Change: -1.53%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sichuan Kelun-Biotech Turns to Profit in H1 as Revenue Jumps 32%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSichuan Kelun-Biotech Turns to Profit in H1 as Revenue Jumps 32%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-20 13:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Sichuan Kelun-Biotech Biopharmaceutical (HKG:6990) swung to an attributable profit of 310.2 million yuan in the first half from a loss of 31.1 million yuan in the year-ago period, according to a ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06990","symbol_name":"科伦博泰生物-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2460046956","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2460046956","pubTimestamp":1724131587,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Sichuan Kelun-Biotech Biopharmaceutical  swung to an attributable profit of 310.2 million yuan in the first half from a loss of 31.1 million yuan in the year-ago period, according to a Monday filing with the Hong Kong stock exchange.The biopharmaceutical company turned to EPS of 1.41 yuan from a loss per share of 0.17. Analysts at Visible Alpha estimated a loss per share of 1.17 yuan.Revenue grew 32% to 1.38 billion yuan from 1.05 billion yuan a year earlier. Visible Alpha analysts forecast revenue at 7.11 billion yuan.Shares slid 2% during Tuesday's afternoon trading.Price : $166.80, Change: $-2.6, Percent Change: -1.53%","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"06990":"科伦博泰生物-B"},"translate_title":"四川科伦生物上半年扭亏为盈，收入增长32%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06990":0.9},"content_text":"Sichuan Kelun-Biotech Biopharmaceutical (HKG:6990) swung to an attributable profit of 310.2 million yuan in the first half from a loss of 31.1 million yuan in the year-ago period, according to a Monday filing with the Hong Kong stock exchange.The biopharmaceutical company turned to EPS of 1.41 yuan from a loss per share of 0.17. Analysts at Visible Alpha estimated a loss per share of 1.17 yuan.Revenue grew 32% to 1.38 billion yuan from 1.05 billion yuan a year earlier. Visible Alpha analysts forecast revenue at 7.11 billion yuan.Shares slid 2% during Tuesday's afternoon trading.Price (HKD): $166.80, Change: $-2.6, Percent Change: -1.53%","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2460046956"}